Population Pharmacokinetic and Exposure–Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia
Crossref DOI link: https://doi.org/10.1007/s40262-017-0556-y
Published Online: 2017-06-03
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moser, Brian A.
LaBell, Elizabeth S.
Chigutsa, Emmanuel
Jakubowski, Joseph A.
Small, David S.
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2017-06-03